Wolfgang Naumann

Title: Innovations by Wolfgang Naumann

Introduction

Wolfgang Naumann is a notable inventor based in Zug, Germany. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of controlled release systems for LHRH antagonists.

Latest Patents

Wolfgang Naumann holds two patents related to the preparation of immobilized and activity-stabilized complexes of LHRH antagonists. His latest inventions focus on creating a release-delaying system for cetrorelix, allowing for controlled release over several weeks. The process involves complexation with biophilic carriers, specifically acidic polyamino acids such as polyglutamic acid and polyaspartic acid. The cetrorelix polyamino acid complexes are prepared from aqueous solutions, followed by precipitation and drying processes. In animal experiments, these complexes demonstrated the ability to suppress testosterone in male rats for over 600 hours, showcasing the effectiveness of the controlled release mechanism.

Career Highlights

Wolfgang Naumann is associated with Asta Medica, Aktiengesellschaft, where he has been instrumental in advancing research in biopharmaceuticals. His work has contributed to the understanding and application of LHRH antagonists in therapeutic settings.

Collaborations

He has collaborated with notable colleagues, including Jurgen Engel and Wolfgang Deger, to further enhance the research and development of innovative pharmaceutical solutions.

Conclusion

Wolfgang Naumann's contributions to the field of biopharmaceuticals through his patents and collaborative efforts highlight his role as a significant inventor in the industry. His work continues to influence the development of effective therapeutic systems.